Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000963

Drug Information
NameRisperidone Consta    
CompanyJohnson & Johnson    
IndicationBipolar disorderPhase IV    [1]
CAS NumberCAS 106266-06-2
FormularC23H27FN4O2    
ChEBI8871;    
SuperDrug ATC IDN05AX08;    
SuperDrug CAS ID106266062;    
ClinicalTrials.govNCT00571688;    
Target5-hydroxytryptamine receptor 2A Antagonist[1]
5-hydroxytryptamine receptor 2A Multitarget[1]
D(2) dopamine receptor Antagonist[1]
D(2) dopamine receptor Multitarget[1]
Ref 1Emerging drugs for bipolar disorder. Expert Opin Emerg Drugs. 2006 Nov;11(4):621-34. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543